Parabilis Medicines (formerly FogPharma) is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, developing a new class of ultra-tunable alpha-helical peptide therapeutics called Helicons to reach intracellular protein targets long considered undruggable. - View it on GitHub